Literature DB >> 31925414

Patient Engagement With an Automated Telephone Symptom Management Intervention: Predictors and Outcomes.

Alla Sikorskii1, Charles W Given2, Barbara A Given2, Asish Banik3, John C Krauss4.   

Abstract

BACKGROUND: Self-management of symptoms related to cancer and its treatment is important for maintaining treatment regimens and improving outcomes.
PURPOSE: To determine factors associated with engagement in a symptom self-management intervention among patients initiating oral anticancer treatment.
METHODS: This secondary analysis included 127 patients randomized to the medication adherence reminder and symptom management intervention in a recently completed trial. Patients were recruited from six Comprehensive Cancer Centers, interviewed at intake, and mailed a Symptom Management Toolkit (Toolkit) with self-care management strategies for 18 symptoms. During eight automated telephone weekly calls, patients were asked to use the Toolkit to manage elevated symptoms. Toolkit use and symptoms were tracked weekly, and generalized linear mixed-effects models were used to determine factors predictive of Toolkit use. General linear modeling was used to relate the Toolkit use during intervention to postintervention symptom severity.
RESULTS: Better cognitive function at intake into the trial and higher symptom burden were predictive of the patients' initial decision to try the Toolkit during Week 1. In subsequent weeks, Toolkit use in the previous week and worsening of symptoms were associated with greater odds of Toolkit use. The extent of Toolkit use modified the relationship between intake and 8 week symptom severity: among patients with higher levels of severity at intake, use of the Toolkit conferred greater benefit at 8 weeks.
CONCLUSIONS: Patients make realistic decisions regarding when to use a self-directed approach to self-management and are likely to use strategies when their symptoms are higher and to forego use once symptoms subside. CLINICAL TRIAL REGISTRATION: NCT02043184. © Society of Behavioral Medicine 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Cancer; Intervention; Oral agents; Self-management; Symptoms

Mesh:

Substances:

Year:  2020        PMID: 31925414      PMCID: PMC7291323          DOI: 10.1093/abm/kaz067

Source DB:  PubMed          Journal:  Ann Behav Med        ISSN: 0883-6612


  42 in total

1.  Effects of depressive symptomatology on cancer-related symptoms during oral oncolytic treatment.

Authors:  Veronica Decker; Alla Sikorskii; Charles W Given; Barbara A Given; Eric Vachon; John C Krauss
Journal:  Psychooncology       Date:  2018-10-23       Impact factor: 3.894

2.  Chemotherapy in head and neck cancer: clinical predictors of tolerance and outcomes.

Authors:  Gregory J Kubicek; Bruce F Kimler; Fen Wang; Eashwer K Reddy; Douglas A Girod; Steven K Williamson
Journal:  Am J Clin Oncol       Date:  2011-08       Impact factor: 2.339

3.  The Relationship Between Depressive Symptoms and Self-Management Behaviors in Patients With T2DM and Stage 3 CKD.

Authors:  Teresa J Sakraida; Mary T Weber
Journal:  Perspect Psychiatr Care       Date:  2015-06-11       Impact factor: 2.186

4.  Chemotherapy interruptions in relation to symptom severity in advanced breast cancer.

Authors:  Gwen Wyatt; Alla Sikorskii; Irena Tesnjak; David Victorson; Gordan Srkalovic
Journal:  Support Care Cancer       Date:  2015-03-25       Impact factor: 3.603

5.  Latent Class Analysis Reveals Distinct Subgroups of Patients Based on Symptom Occurrence and Demographic and Clinical Characteristics.

Authors:  Christine Miaskowski; Laura Dunn; Christine Ritchie; Steven M Paul; Bruce Cooper; Bradley E Aouizerat; Kimberly Alexander; Helen Skerman; Patsy Yates
Journal:  J Pain Symptom Manage       Date:  2015-01-31       Impact factor: 3.612

6.  Development of an intervention program to increase effective behaviours by patients and clinicians in psychiatric services: Intervention Mapping study.

Authors:  Bauke Koekkoek; Berno van Meijel; Aart Schene; Giel Hutschemaekers
Journal:  BMC Health Serv Res       Date:  2010-10-25       Impact factor: 2.655

7.  Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy.

Authors:  Charles Given; Barbara Given; Mohammad Rahbar; Sangchoon Jeon; Ruth McCorkle; Bernadine Cimprich; Andrzej Galecki; Sharon Kozachik; Albert Brady; Mary Jo Fisher-Malloy; Kathy Courtney; Elizabeth Bowie
Journal:  J Clin Oncol       Date:  2004-02-01       Impact factor: 44.544

8.  Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States.

Authors:  Dima Mazen Qato; Katharine Ozenberger; Mark Olfson
Journal:  JAMA       Date:  2018-06-12       Impact factor: 56.272

9.  The Influence of Health Literacy and Depression on Diabetes Self-Management: A Cross-Sectional Study.

Authors:  D Maneze; B Everett; C Astorga; D Yogendran; Y Salamonson
Journal:  J Diabetes Res       Date:  2016-08-10       Impact factor: 4.011

Review 10.  Methods used to address fidelity of receipt in health intervention research: a citation analysis and systematic review.

Authors:  Lorna Rixon; Justine Baron; Nadine McGale; Fabiana Lorencatto; Jill Francis; Anna Davies
Journal:  BMC Health Serv Res       Date:  2016-11-18       Impact factor: 2.655

View more
  1 in total

1.  Mobile App for Symptom Management and Associated Quality of Life During Systemic Treatment in Early Stage Breast Cancer: Nonrandomized Controlled Prospective Cohort Study.

Authors:  Nina Ružić Gorenjec; Cvetka Grašič Kuhar; Tjaša Gortnar Cepeda; Timotej Kovač; Matjaž Kukar
Journal:  JMIR Mhealth Uhealth       Date:  2020-08-04       Impact factor: 4.773

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.